Study of Unresectable HCC Treated Concomitantly With TACE and Sorafenib in Chinese Patients
Observational Model: Case Control, Time Perspective: Prospective
Summarized patient characteristics
Patient characteristics are hepatic virus infection status, surgery history, tumor size, number of tumor, macroscopic vascular invasion (MVI), extra-hepatic spread (EHS), cirrhosis, ECOG score, Child-Pugh score, BCLC stage, etc.
up to 3 years
Bayer Study Director
China: Food and Drug Administration